Acuson sells 10 echo units to Health First

Article

Ultrasound vendor Acuson scored a coup this month when it sold 10 echocardiography systems, combined with its KinetDx PACS product, to Health First Heart Institute of Brevard, FL. Health First has installed one of Acuson’s Aspen units and

Ultrasound vendor Acuson scored a coup this month when it sold 10 echocardiography systems, combined with its KinetDx PACS product, to Health First Heart Institute of Brevard, FL. Health First has installed one of Acuson’s Aspen units and nine of its Sequoia C256 units, along with KinetDx, at hospitals and clinics in its network: Cape Canaveral Hospital, Palm Bay Community Hospital, Health First Healthplex Outpatient Clinic, and Holmes Regional Medical Center. The Aspen and Sequoia systems will include Acuson’s Imagegate hardware and software upgrade package, which it launched in September (SCAN 9/15/99).

Acuson introduced KinetDx in April at the Symposium for Computer Applications in Radiology in Houston (SCAN 5/12/99). KinetDx will link all four of Health First’s facilities into a single network.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.